Better Therapeutics(BTTX) - 2023 Q3 - Earnings Call Transcript

Operator Our first opportunity to engage directly with healthcare providers was at this year's American College of Lifestyle Medicine's annual meeting a couple of weeks ago, and it was exciting to see the strong interest in AspyreRx. Thanks, Frank. It is exciting to be at this point launching a AspyreRx into the market and continuing to build up our commercial footprint to drive awareness and educate providers. And with that, I thought I'd start by sharing initial reactions since our market release. We have ...